| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/14/2001 | EP1083181A1 Process for the preparation of O-acetyl sialic acid specific immunoglobulin and method of quantification thereof |
| 03/14/2001 | EP1082967A1 Preventives/remedies for autoimmune demyelinating diseases |
| 03/14/2001 | EP1082441A1 Mycobacterial n-acetyltransferases |
| 03/14/2001 | EP1082435A2 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 03/14/2001 | EP1082433A1 Interleukins-21 and 22 |
| 03/14/2001 | EP1082432A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
| 03/14/2001 | EP1082430A1 Kunitz domain polypeptide and materials and methods for making it |
| 03/14/2001 | EP1082428A2 Inhibition of viral infection and spread with viral and rhoa-derived peptides |
| 03/14/2001 | EP1082426A2 Human socs proteins |
| 03/14/2001 | EP1082424A1 Tumor suppressor |
| 03/14/2001 | EP1082420A2 Human nucleic acid sequences from normal pancreas tissue |
| 03/14/2001 | EP1082413A2 Aav5 vector and uses thereof |
| 03/14/2001 | EP1082346A1 Specific binding proteins for treating canine allergy |
| 03/14/2001 | EP1082344A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 03/14/2001 | EP1082341A2 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
| 03/14/2001 | EP1082340A1 Peptide vaccine for canine allergy |
| 03/14/2001 | EP1082336A2 Apoptosis modulators that interact with the huntington's disease gene |
| 03/14/2001 | EP1082335A1 Novel secreted and membrane-associated proteins and uses therefor |
| 03/14/2001 | EP1082334A1 Alg-2lp, alg-2 like molecules and uses therefor |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/14/2001 | EP1082141A1 Cd40 binding molecules and ctl peptides for treating tumors |
| 03/14/2001 | EP1082137A1 REVERSAL OF PROINFLAMMATORY RESPONSE BY LIGATING THE MACROPHAGE Fc$g(g)RI RECEPTOR |
| 03/14/2001 | EP1082136A1 The cytokine family member, 2-19 |
| 03/14/2001 | EP1082096A1 Skin treatment compositions and the use thereof |
| 03/14/2001 | EP0671472B1 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody |
| 03/14/2001 | EP0640143B1 Senescent cell derived inhibitors of dna synthesis |
| 03/14/2001 | EP0584279B1 Targeted delivery of genes encoding immunogenic proteins |
| 03/14/2001 | CN1287125A Method of extracting immune globulin A from milk |
| 03/13/2001 | US6201109 Immunoassay detection of bone isoenzyme in sample using two antibodies which specifically bind to different epitopes of enzyme to form an immunocomplex; noninvasive monitoring of bone formation |
| 03/13/2001 | US6201108 Antibodies which bind to mammalian transforming growth factor-beta type ii receptor; treatment of bone disorders; anticarcinogenic/antimetastasis agents |
| 03/13/2001 | US6201107 Cystic fibrosis gene |
| 03/13/2001 | US6201106 Cytokine signal regulators |
| 03/13/2001 | US6201105 Amino acid sequence; treatment of septic shock and cachexia; diagnosis |
| 03/13/2001 | US6201103 Peptide nucleic acid incorporating a chiral backbone |
| 03/13/2001 | US6200951 For detecting chitin, binding chitin, and treating fungal infections or for development of products useful for fungal infection therapy |
| 03/13/2001 | US6200801 A polycation and a binding moiety of defined amino acid sequence capable of binding to a serpin enzyme complex receptor for targeted gene delivery; gene therapy; antisense agents |
| 03/13/2001 | US6200787 Phenylalanyl tRNA synthetase polypeptides from streptococcus pneumoniae |
| 03/13/2001 | US6200780 Human interferon-ε(IFN-ε), a type I interferon |
| 03/13/2001 | US6200779 Nucleotide sequences which code protein associated with bacterial infection; for prevent of infections and associated defects |
| 03/13/2001 | US6200777 Human p101 polynucleotides |
| 03/13/2001 | US6200776 Polynucleotides encoding human sodium bicarbonate cotransporters |
| 03/13/2001 | US6200775 Nucleotide sequence coding a polypeptide associated with the diagnosis and treatment of infections |
| 03/13/2001 | US6200774 Compounds |
| 03/13/2001 | US6200770 Protein kinase molecules and uses therefor |
| 03/13/2001 | US6200768 Detecting compounds efficient in the dissolution of an alzheimer's protein; incubate preferential protein with kinase, monitor helix formation, incubate with modulator and detect blocking action by modulator |
| 03/13/2001 | US6200766 Methods and reagents for quantitation of HLA-DR expression on peripheral blood cells |
| 03/13/2001 | US6200764 Monitoring activated g-protein in a bodily fluid; incubating bodily fluid with an immobilized monocolnal antibody, screen for signal in sample |
| 03/13/2001 | US6200763 Detecting cell expressing myeloid polypeptide; incubate cell with binding substance and detecting bound substance, presence of bound protein indicates cell expressing myeloid protein |
| 03/13/2001 | US6200749 Ajusted nucleic acid sequence; for detection of genome adjustments and preferential genetic disorders |
| 03/13/2001 | US6200606 Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration |
| 03/13/2001 | US6200578 Genetic engineered polypeptide |
| 03/13/2001 | US6200575 These new ?inactivated? immunogens can be used to induce active immunization in humans which is capable of preventing or correcting the deregulatory effects which the native proteins from which they are produced may help to produce. |
| 03/13/2001 | US6200567 An antibody that binds to the common beta c chain of the receptor for gm-csf, il-3 and il-5 |
| 03/13/2001 | US6200566 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy |
| 03/13/2001 | US6200565 Oral administration of immunoglobulins for treating autoimmune hearing loss |
| 03/13/2001 | CA2125673C Dna structure-specific recognition protein and uses therefor |
| 03/08/2001 | WO2001016319A2 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | WO2001016318A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | WO2001016315A1 sIGH AFFINITY CHOLINE TRANSPORTER |
| 03/08/2001 | WO2001016308A2 Plant sterol acyltransferases |
| 03/08/2001 | WO2001016303A2 Nucleic acids which code for the enzyme activities of the spinosyn biosynthesis |
| 03/08/2001 | WO2001016297A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | WO2001016293A2 Dna encoding the human serine protease t |
| 03/08/2001 | WO2001016292A2 37 staphylococcus aureus genes and polypeptides |
| 03/08/2001 | WO2001016290A2 Dna encoding the human serine protease eos |
| 03/08/2001 | WO2001016288A2 Dna encoding the human serine protease c-e |
| 03/08/2001 | WO2001016183A1 Monoclonal antibodies and vaccines against epitopes on the ebola virus glycoprotein |
| 03/08/2001 | WO2001016180A2 Cd40 agonist compositions and methods of use |
| 03/08/2001 | WO2001016172A1 Vaccine antigens of moraxella |
| 03/08/2001 | WO2001016170A2 Card proteins involved in cell death regulation |
| 03/08/2001 | WO2001016165A2 Apoptin-associating protein |
| 03/08/2001 | WO2001016156A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | WO2001016155A1 Antibodies specific for fullerenes |
| 03/08/2001 | WO2001015732A1 Remedies for immunological diseases |
| 03/08/2001 | WO2001015731A1 Compositions and methods for the treatment of sepsis using antibodies to c5a |
| 03/08/2001 | WO2001015730A1 DOSAGES FOR TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 03/08/2001 | WO2001015729A1 Connective tissue growth factor receptor, its agonists and antagonists, and their therapeutic and diagnostic uses |
| 03/08/2001 | WO2001015728A1 Method for activating cytotoxic t-lymphocytes (ctls) in vivo : composition comprising antibody anti cd40 (or cd40l or cd40 binding protein) and an antigen |
| 03/08/2001 | WO2001015708A1 Vaccine to control equine protozoal myeloencephalitis in horses |
| 03/08/2001 | WO2000066735A3 Human ion channel proteins |
| 03/08/2001 | WO2000064327A3 Inhibition of complement action |
| 03/08/2001 | WO2000061624A8 48 human secreted proteins |
| 03/08/2001 | WO2000058475A3 Streptococcus pneumoniae antigens |
| 03/08/2001 | WO2000039283A8 Use of cd40 engagement to alter t cell receptor usage |
| 03/08/2001 | WO2000038786A3 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 03/08/2001 | WO2000023588A8 G-protein coupled receptors |
| 03/08/2001 | WO2000020447A8 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |
| 03/08/2001 | CA2645727A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2481788A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2481756A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2481691A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2481685A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2388734A1 37 staphylococcus aureus genes and polypeptides |
| 03/08/2001 | CA2387291A1 Dna encoding the human serine protease t |
| 03/08/2001 | CA2384055A1 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | CA2384026A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | CA2383784A1 Apoptin-associating protein |
| 03/08/2001 | CA2383693A1 Card proteins involved in cell death regulation |
| 03/08/2001 | CA2383601A1 Dna encoding the human serine protease eos |